Competing interests
TMM has, via his institution, received industry-academic funding from AstraZeneca and GlaxoSmithKline R&D, and has received consultancy or speakers’ fees from AstraZeneca, Bayer, Blade Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Fibrogen, Galapagos, GlaxoSmithKline R&D, IQVIA, Pliant, F. Hoffmann-La Roche, Ltd., Trevi and Veracyte.
MK has received fees for speaking and/or organising education from AstraZeneca, Bayer, Boehringer Ingelheim, Chiesi, ERS, F. Hoffmann-La Roche, Ltd., GlaxoSmithKline and Novartis, has received fees for consulting from Boehringer Ingelheim, F. Hoffmann-La Roche, Ltd., Galapagos, GlaxoSmithKline, and InterMune, and has received research funding, including institutional funding, from Boehringer Ingelheim, BMBF, DFG, the German Center for Lung Research (DZL), F. Hoffmann-La Roche, Ltd., Dietmar Hopp Stiftung, InterMune, Lilly, Lungenfibrose e.V., medac Pharma, Olympus, UKGM and WATL.
CCM has received unrestricted grants and speaker and/or advisory board fees from Boehringer Ingelheim and F. Hoffmann-La Roche, Ltd. All grants and fees were paid to the Erasmus University Medical Center in Rotterdam, The Netherlands.
SDN is a consultant and is on the speakers’ bureau for F. Hoffmann-La Roche, Ltd. and Boehringer Ingelheim. His institution has received research funding from both companies. SDN is also a consultant for Bellerophon and United Therapeutics.
JS is a paid consultant for Lung Therapeutics, an unpaid consultant for Boehringer Ingelheim, and has received grant support from Boehringer Ingelheim and Genentech, Inc.
JA, MB and KUK are employees and shareholders of F. Hoffmann-La Roche, Ltd.
PB and CS are employees of Genentech, Inc.
FG is an employee of F. Hoffmann-La Roche, Ltd.
MSW has received unrestricted grants and speaker fees from Boehringer Ingelheim and F. Hoffmann-La Roche, Ltd., and advisory board fees from BMS, Galapagos, Galecto, Horizon, NeRRe Therapeutics and Novartis. All grants and fees were paid to the Erasmus University Medical Center in Rotterdam, The Netherlands.